Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2014
Reporting Period: Second Quarter ended June 30, 2014
This filing serves to announce the Company's financial results for the quarter ended June 30, 2014, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only references the issuance of the press release containing the second-quarter 2014 financial and business highlights.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release titled "Capricor Therapeutics Reports Second Quarter 2014 Financial & Business Highlights."
Legal Disclaimer: The information under Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed filed for purposes of Section 18 of the Exchange Act, nor subject to its liabilities, unless expressly incorporated by reference.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific Q2 2014 revenue, net loss, and cash position figures.
- Verify the Company's cash runway and burn rate as disclosed in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the business highlights.
- Confirm if the furnished information has been incorporated by reference into other SEC filings.